Yap, T. A., Harano, K., Eng, C., Subbiah, V., Gatti-Mays, M. E., Moyers, J. T., Murakami, R., Li, J., Iino, S., Robson, P., Zhang, L., Qu, J., Peddagali, V., Sbar, E. I., Shah, J. J., Falchook, G. S. (2026). First data disclosure from the first-in-human phase 1/2 trial of SMP-3124LP, the first investigational pegylated liposome CHK1 inhibitor, in patients with selected advanced solid tumors.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.3081